Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

RxHealth Value Will Participate In HHS Pricing Conference; PhRMA Declines

Executive Summary

RxHealth Value Executive Director John Golenski, PhD, will be among participants in the Aug. 8-9 HHS pharmaceutical pricing conference.

You may also be interested in...



Drug Pricing Strategies To Be Discussed At HHS Drug Conference In August

The pharmaceutical industry's methods for arriving at drug prices will be considered at an HHS conference in August.

Consumer/Payor Coalition Researching Rx Patent Issues; FDA Changes Urged

The RxHealth Value consumer/payor coalition plans to issue a report on the impact of patent extensions on the pharmaceutical market by this summer.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

UsernamePublicRestriction

Register

LL1133951

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel